Flex Pharma (FLKS) Offers Regulatory, Clinical Update for FLX-787 for Treatment of Nocturnal Leg Cramp

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 5/21/2022

1. SPY
2. AMAT
3. PANW
4. ROST
5. TSLA
6. VFC
7. DECK
8. DIA
9. QQQ
10. DE

Go back to Flex Pharma (FLKS) Offers Regulatory, Clinical Update for FLX-787 for Treatment of Nocturnal Leg Cramp

Cantor Fitzgerald Downgrades Flex Pharma (FLKS) to Hold

October 14, 2016 8:44 AM EDT

Cantor Fitzgerald downgraded Flex Pharma (NASDAQ: FLKS) from Buy to Hold with a price target of $10.00 (from $22.00).

For an analyst ratings summary and ratings history on Flex Pharma click here. For more ratings news on Flex Pharma click here.

Shares of Flex Pharma closed at $8.43 yesterday.

... More